Published in Gastroenterology on September 01, 1966
Pathogenesis of jejunal mucosal alterations: synechia formation. Am J Pathol (1967) 0.78
Treatment of overt and subclinical malabsorption in Haiti. Gut (1969) 0.76
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Pepsinogens: genetic polymorphism in man. Science (1970) 3.07
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology (1982) 3.05
Genetic heterogeneity of hyperpepsinogenemic I and normopepsinogenemic I duodenal ulcer disease. Ann Intern Med (1979) 2.61
Gastric acidity in older adults. JAMA (1997) 2.34
Enterotoxigenic intestinal bacteria in tropical sprue. Ann Intern Med (1973) 2.07
Stable antibody-producing murine hybridomas. Science (1983) 2.06
Human anticentromere antibodies: distribution, characterization of antigens, and effect on microtubule organization. Cell (1983) 2.04
Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum, and gastric mucosa. Gastroenterology (1970) 1.92
Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology (1973) 1.82
Enterotoxigenicity of enteropathogenic serotypes of Escherichia coli isolated from infants with epidemic diarrhea. Infect Immun (1978) 1.74
Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology (1982) 1.72
Immunological and physicochemical characterization of heat-labile enterotoxins isolated from two strains of Escherichia coli. Infect Immun (1982) 1.70
Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology (1975) 1.68
Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria. Infect Immun (1977) 1.67
Histochemical methods for separate, consecutive and simultaneous demonstration of acetylcholinesterase and norepinephrine in cryostat sections. J Histochem Cytochem (1967) 1.65
Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology (1971) 1.64
Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations. Infect Immun (1985) 1.63
Long-term follow-up of antibiotic-treated tropical sprue. Ann Intern Med (1972) 1.61
Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med (1979) 1.61
Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol (1983) 1.59
Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet (1985) 1.55
Celiac disease and multiple jejunal diverticulosis. Am J Dig Dis (1967) 1.55
Chemical synthesis of an octadecapeptide with the biological and immunological properties of human heat-stable Escherichia coli enterotoxin. Eur J Biochem (1984) 1.51
Population studies of pepsinogen polymorphism. Am J Hum Genet (1973) 1.50
Properties of crude Campylobacter jejuni heat-labile enterotoxin. Infect Immun (1984) 1.49
Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial. Gastroenterology (1978) 1.47
Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin. J Clin Microbiol (1984) 1.47
Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology (1983) 1.44
Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin. Infect Immun (1982) 1.44
Tricuspid candida endocarditis complicating a permanently implanted transvenous pacemaker. Am Heart J (1969) 1.41
Radioimmunoassay of group I pepsinogens in serum. Gastroenterology (1974) 1.40
Predisposition to spina bifida: Search for a relation to maternal gastric acid secretion. J Med Genet (1977) 1.38
Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin. Infect Immun (1982) 1.36
Slow moving protease and the seven pepsinogens. Electrophoretic demontration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology (1969) 1.35
Tamm-Horsfall mucoprotein. I. Localization in the kidney. Lab Invest (1971) 1.35
Immunofluorescence counterstains. J Histochem Cytochem (1974) 1.31
Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxin. J Infect Dis (1983) 1.29
Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl (1991) 1.28
Assay of Escherichia coli enterotoxins by in vivo perfusion in the rat jejunum. Infect Immun (1976) 1.28
Effect of Klebsiella pneumoniae enterotoxin on intestinal transport in the rat. J Clin Invest (1975) 1.27
Contamination of the small intestine by enterotoxigenic coliform bacteria among the rural population of Haiti. Gastroenterology (1976) 1.25
Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol (1992) 1.25
Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology (1971) 1.25
Selective binding of sucralfate to gastric ulcer in man. Dig Dis Sci (1981) 1.24
Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun (1981) 1.24
Rapid Grocott's methenamine--silver nitrate method for fungi and Pneumocystis carinii. Am J Clin Pathol (1977) 1.22
Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Intern Med (1981) 1.21
Morphologic characteristics of jejunal biopsy in celiac disease and tropical sprue. Am J Pathol (1965) 1.20
Properties of synthetically produced Escherichia coli heat-stable enterotoxin. Infect Immun (1983) 1.20
Dual innervation of the mammalian urinary bladder. A histochemical study of the distribution of cholinergic and adrenergic nerves. Am J Anat (1966) 1.20
Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol (2000) 1.19
Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit. Infect Immun (1983) 1.19
Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins. Infect Immun (1985) 1.18
Enzyme-linked immunosorbent assays for virulence properties of Campylobacter jejuni clinical isolates. J Clin Microbiol (1986) 1.17
Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats. Infect Immun (1979) 1.17
Purification and properties of Klebsiella pneumoniae heat-stable enterotoxin. Infect Immun (1976) 1.17
Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine. Infect Immun (1983) 1.17
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology (1986) 1.16
Tropical sprue in Haiti. Ann Intern Med (1966) 1.16
Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin. Infect Immun (1980) 1.15
Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet (1968) 1.14
Protection in rats immunized with Escherichia coli heat-stable enterotoxin. Infect Immun (1981) 1.13
Actions of histamine, secretin, and PGE2 on cyclic AMP production by isolated canine fundic mucosal cells. Am J Physiol (1979) 1.13
A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology (1975) 1.13
Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli. Infect Immun (1981) 1.11
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci (1993) 1.10
Identification of intrinsic factor autoantibody and intrinsic factor in man by radioimmunodiffusion and radioimmunoelectrophoresis. J Immunol (1965) 1.10
Partial purification and properties of Enterobacter cloacae heat-stable enterotoxin. Infect Immun (1976) 1.10
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev (1996) 1.10
Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res (1966) 1.09
Enterotoxigenic Campylobacter jejuni among children in South India. Lancet (1984) 1.08
Effect of fat on meal-stimulated duodenal acid load, duodenal pepsin load, and serum gastrin in duodenal ulcer and normal subjects. Gastroenterology (1978) 1.07
Serum pepsinogens I and II and stomach cancer. Clin Chim Acta (1987) 1.07
Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol (1998) 1.06
Cloning and molecular characterization of the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 1.06
A new theory of the innervation of bladder musculature. 4. Innervation of the vesicourethral junction and external urethral sphincter. J Urol (1974) 1.05
Life events stress and psychosocial factors in men with peptic ulcer disease. II. Relationships with serum pepsinogen concentrations and behavioral risk factors. Gastroenterology (1988) 1.04
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators. J Am Geriatr Soc (1986) 1.04
Enterotoxigenic intestinal bacteria in tropical sprue. II. Effect of the bacteria and their enterotoxins on intestinal structure. Gastroenterology (1975) 1.03
Relationships between the human pepsinogen DNA and protein polymorphisms. Am J Hum Genet (1986) 1.03
Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology (1990) 1.03
Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients. Gastroenterology (1988) 1.03
Age- and sex-related behaviour of gastric acid secretion at the population level. Scand J Gastroenterol (1982) 1.02
Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev (1993) 1.02
Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med (1987) 1.02
Megaloblastic anemia of pregnancy in New York City. Ann Intern Med (1967) 1.01
Intestinal perfusion studies in tropical sprue. I. Transport of water, electrolytes, and d-xylose. Gastroenterology (1973) 1.01
Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli. Infect Immun (1980) 1.01
Folate deficiency secondary to disease of the intestinal tract. Bull N Y Acad Med (1966) 0.99
Slow moving proteinase. Isolation, characterization, and immunohistochemical localization in gastric mucosa. Gastroenterology (1987) 0.99
Blocking and binding antibodies to intrinsic factor and parietal call antibody in pernicious anemia. Gastroenterology (1968) 0.99
Autonomic innervation of the rat vagina, cervix, and uterus and its cyclic cariation. Am J Obstet Gynecol (1969) 0.99